Muken Ross 4
4 · SOPHiA GENETICS SA · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) President Muken Ross Receives Award
What Happened
Muken Ross, President of SOPHiA GENETICS SA (SOPH), received equity awards on April 2, 2026: 431,211 restricted stock units (RSUs) and 628,743 derivative awards (share options), for a total of 1,059,954 share-equivalents. Both grants were reported at $0.00 (no cash paid at grant); these are compensation awards, not open-market purchases or sales.
Key Details
- Transaction date: 2026-04-02; Form 4 filed 2026-04-03 (next day).
- Grant amounts/prices: 431,211 RSUs @ $0.00; 628,743 derivative awards @ $0.00. Total = 1,059,954.
- Shares owned after transaction: Not disclosed in the filing.
- Vesting notes (from filing):
- RSUs: 25% vest on April 2, 2027; remaining 75% vest in equal quarterly installments through April 2, 2030. (F1)
- Options: 25% vests on April 2, 2027; remaining vest in equal monthly installments through April 2, 2030. (F2)
- Timeliness: Filing appears timely (filed the day after the grant); no late filing indicated.
Context
These are compensation grants (RSUs and options) that convert to actual shares only as they vest; they do not represent an immediate purchase or sale. Derivative awards (options) give the holder a future right tied to vesting; exercise (and any subsequent sale) would be reported separately. Such grants are common executive compensation and, by themselves, are not a direct market signal.
Insider Transaction Report
- Award
Ordinary Shares
[F1]2026-04-02+431,211→ 431,211 total - Award
Share Option (Right to Buy)
[F2]2026-04-02+628,743→ 628,743 totalExercise: $5.04Exp: 2036-04-02→ Ordinary Shares (628,743 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") grant made under the Issuer's 2021 Equity Incentive Plan. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. 25% of the RSUs will vest on April 2, 2027, and the remaining 75% will vest in equal quarterly installments through April 2, 2030.
- [F2]The share option vests and becomes exercisable as to 25% of the ordinary shares on April 2, 2027, and then in equal monthly installments through April 2, 2030.